J-STAR Research, Inc., is pleased to announce the completion of the synthesis and delivery of a cGMP batch of an Epothilone derivative to support clinical trials as a potential treatment of cancer.

The Epothilones are a class of naturally occurring bacterial metabolites which possess cytotoxic and antifungal properties.

The complex synthetic sequence employed 35 synthetic steps and constitutes another milestone achievement in the history of our company.

This challenging project highlights our capabilities to scale up (cGMP) and synthesize a complex natural product with potential life saving application.

Our staff of expert scientists with combined experience in medicinal and process chemistry is available to support your complex research and scale up needs.